Hi, what are you looking for?
– Credit Suisse sees Copaxone sales falling from $4 billion annually to $400, 000 in 2019 and predicts annual sales of over $1 billion...
The Laquinimod-treated patients accumulated significantly less brain tissue damage caused by neurodegeneration, compared to placebo in MRI analyses.
– The 3D printer company’s secondary offering is an opportunity to look at its remarkable stock market performance, and the people who benefit from...
– Levin announced that will be leaving his post as head of UBM, the international events organizers in 2014. – David Levin / Getty...
– The Enzymotec founder discusses the nutritional supplements company, which is planning a Nasdaq IPO. – Dr. Sobhi Basheer – / By Gali Weinreb...
– Opko Health will have the tenth highest market cap on the Tel Aviv 25 Index. – Phillip Frost / Getty – / By...
– Products developed by the Weizmann Institute have $20 billion in annual sales. – – / By Gali Weinreb / The campus of the...
– Dr. Phillip Frost, the chairman of both Opko and Prolor, has the right to vote on the merger of the two companies on...
– Six dual-listed companies with an aggregate market cap of NIS 6.5 billion delisted from the TASE in 2010-12. – – / By Shiri...
– Apoptosis – /By Alan Gallindoss / Apotex has developed new molecular-level imaging technology to detect diseases within human cells, and potentially help therapeutically...